Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 14, 2018 | Ansun BioPharma | $85.0M Series A | Lilly Asia Ventures, Sinopharm Capital | 3E Bioventures Capital, LYFE Capital, Matrix Partners China, Oceanpine Capital, VI Ventures, YuanMing Capital |